menu search

TDOC / Teladoc Endorsement Could Be Positive for This ETF

Teladoc Endorsement Could Be Positive for This ETF
Healthcare innovation equities are languishing, but it could time for one of the most well-known names in the group to turn around, and that could be constructive for select exchange traded funds, including the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG). In a note to clients on Friday, Goldman Sachs analyst Cindy Motz initiated coverage [. Read More
Posted: Feb 14 2022, 16:57
Author Name: ETF Trends
Views: 110218

TDOC News  

Teladoc Health (TDOC) Q3 Loss Narrows on Integrated Care Strength

By Zacks Investment Research
October 25, 2023

Teladoc Health (TDOC) Q3 Loss Narrows on Integrated Care Strength

Teladoc Health's (TDOC) Q3 results were aided by membership growth in the Integrated Care unit as well as strong BetterHelp revenues. Management prese more_horizontal

Teladoc (TDOC) Stock Slides After Announcing Operational Review

By InvestorPlace
October 25, 2023

Teladoc (TDOC) Stock Slides After Announcing Operational Review

Teledoc Health (NASDAQ: TDOC ) stock fell 6% overnight after announcing a review of its operations and missing earnings estimates. The company also is more_horizontal

Teladoc Earnings: Are Better Days Ahead or Is the Story Over?

By The Motley Fool
October 24, 2023

Teladoc Earnings: Are Better Days Ahead or Is the Story Over?

Teladoc stock is down 7% after the company reported Q3 earnings. Is this Cathie Wood stock still worth it? more_horizontal

Teladoc (TDOC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

By Zacks Investment Research
October 24, 2023

Teladoc (TDOC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Teladoc (TDOC) give a sense of how its business performed in the quarter ended September 2023, it might be worth cons more_horizontal

Teladoc (TDOC) Reports Q3 Loss, Lags Revenue Estimates

By Zacks Investment Research
October 24, 2023

Teladoc (TDOC) Reports Q3 Loss, Lags Revenue Estimates

Teladoc (TDOC) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.37. This compares to loss of $0.4 more_horizontal

Teladoc's stock tumbles after-hours after company misses sales estimates and offers soft guidance

By Market Watch
October 24, 2023

Teladoc's stock tumbles after-hours after company misses sales estimates and offers soft guidance

Teladoc Health Inc.'s stock TDOC, +0.61% tumbled 5.8% in after-hours trading Tuesday, after the virtual care company posted a narrower-than-expected l more_horizontal

Can Growing Visits Aid Teladoc's (TDOC) Earnings in Q3?

By Zacks Investment Research
October 18, 2023

Can Growing Visits Aid Teladoc's (TDOC) Earnings in Q3?

Teladoc's (TDOC) third-quarter results are likely to reflect growth in BetterHelp paying users. more_horizontal

Why the Market Dipped But Teladoc (TDOC) Gained Today

By Zacks Investment Research
October 17, 2023

Why the Market Dipped But Teladoc (TDOC) Gained Today

Teladoc (TDOC) concluded the recent trading session at $19.19, signifying a +1.43% move from its prior day's close. more_horizontal


Search within

Pages Search Results: